NASDAQ$JYNT
The Joint Corp · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
The Joint Corp. reported first quarter 2022 financial results.
The Joint Corp. reported a revenue of $22.4 million, a net loss of $206,000, or $0.01 per share, and an adjusted EBITDA of $1.8 million. The company opened 31 clinics, including 27 franchised, and achieved a milestone of 100 corporate portfolio clinics, bringing total clinics to 736.
- Revenue grew 28% compared to Q1 2021.
- System-wide sales increased 27% compared to Q1 2021.
- System-wide comp sales grew 15% compared to Q1 2021.
- Opened 31 clinics, including 27 franchised - the most for a first quarter in the company’s history.
Headline financials
Revenue & EPS history
The Joint · Revenue · Quarterly
$22.4M
Forward guidance
Management updated its revenue and Adjusted EBITDA guidance to reflect the impact of the macro-economic environment and the impact of increased expenses. Management reaffirmed its guidance for franchised clinic openings and company-owned or managed clinic increases.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
+1.5%
Avg return
Earnings day
+3.3%
Avg return
5 days after
+3.8%
Avg return
30 days after
53%
25 / 47 earnings
Positive
+26.0%
Q1 2024
Best reaction
-42.3%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -2.2% | -6.0% | |
| Q4 2025 | +2.0% | +1.9% | +6.3% | |
| Q3 2025 | -3.9% | +4.6% | +6.1% | |
| Q1 2025 | -5.0% | -5.2% | +14.1% | |
| Q4 2024 | +4.6% | +17.9% | -1.3% | |
| Q3 2024 | -2.8% | -1.7% | -3.1% | |
| Q2 2024 | -5.1% | -3.6% | -8.7% | |
| Q1 2024 | +26.0% | +26.1% | +17.4% | |
| Q4 2023 | +25.7% | +29.8% | +34.8% | |
| Q3 2023 | +1.3% | +4.6% | +15.1% | |
| Q2 2023 | +1.8% | -0.2% | -14.6% | |
| Q1 2023 | -3.1% | -2.2% | -11.2% | |
| Q4 2022 | +2.3% | +1.4% | -1.2% | |
| Q3 2022 | -4.6% | -3.3% | +1.6% | |
| Q2 2022 | +15.2% | +7.8% | -9.6% | |
| Q1 2022 | -42.3% | -43.6% | -46.2% | |
| Q4 2021 | -9.9% | -20.8% | -24.7% | |
| Q3 2021 | +5.8% | +8.6% | -21.8% | |
| Q2 2021 | +18.9% | +17.8% | +22.0% | |
| Q1 2021 | -4.5% | -6.8% | +28.2% | |
| Q4 2020 | -10.0% | -14.9% | -7.0% | |
| Q3 2020 | +7.1% | +28.5% | +35.2% | |
| Q2 2020 | +13.5% | +15.1% | +23.7% | |
| Q1 2020 | +9.9% | +8.8% | +35.6% | |
| Q4 2019 | -3.0% | -10.8% | -42.2% | |
| Q3 2019 | -3.6% | -10.3% | -13.1% | |
| Q2 2019 | -0.1% | +0.0% | -6.2% | |
| Q1 2019 | +8.7% | +4.4% | -7.2% | |
| Q4 2018 | +12.6% | +21.5% | +42.4% | |
| Q3 2018 | +3.8% | +5.5% | +0.5% | |
| Q2 2018 | +8.5% | +3.9% | +2.8% | |
| Q1 2018 | -3.0% | +1.8% | +1.9% | |
| Q4 2017 | +8.2% | +23.7% | +35.9% | |
| Q3 2017 | +16.2% | +23.0% | +8.6% | |
| Q2 2017 | +3.6% | +2.7% | +34.5% | |
| Q1 2017 | +7.3% | +2.6% | -1.3% | |
| Q4 2016 | -15.3% | -11.4% | -15.8% | |
| Q3 2016 | +3.7% | +6.1% | -6.5% | |
| Q2 2016 | -0.5% | -0.9% | +28.9% | |
| Q1 2016 | -0.0% | — | — | |
| Q4 2015 | -21.5% | — | — | |
| Q3 2015 | -6.1% | — | — | |
| Q2 2015 | +1.3% | — | — | |
| Q1 2015 | +6.2% | — | — | |
| Q4 2014 | +4.0% | — | — | |
| Q3 2014 | -1.6% | — | — | |
| Q3 2013 | -1.6% | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro